NuMale Medical Center Announces 98 Percent Success in Treating Erectile Dysfunction


(PRWEB) December 01, 2014

NuMale Medical Center announced today that its erectile dysfunction (ED) therapies have been successful in treating 98 percent of cases. This impressive achievement is a result of NuMales unique approach, which relies on the latest science and most innovative medical techniques and procedures to help men of all ages.

ED is a common problem that affects men of all ages. Nearly one in every five American men suffers from this condition, which becomes more prevalent as men age. Other conditions, including diabetes, prostate problems, cardiovascular disease, and hypertension can contribute to ED as well.

Because the causes of ED can be varied, each patient at NuMale Medical Center receives a comprehensive and confidential medical evaluation including a consultation, a physical examination, and full blood work up. After reviewing the findings of this evaluation, NuMales expert physicians customize a treatment plan to meet each individuals specific needs.

At NuMale, we take this unique approach because it yields better results for patients, said Dr. Asandra. We always treat the patient, not just the symptom. Its more work for our physicians, but its also why we have been so successful in helping men suffering from ED.

NuMale Medical Center has grown rapidly since its founding in May of 2013. With eight offices nationwide and many more to come, NuMale has treated tens of thousands of men suffering from ED, premature ejaculation, low testosterone (Low-T), hair loss, and more.

Using FDA-approved methods and the most innovative treatments, NuMale Medical Center provides a money-back guarantee on its ED consultation for new patients. For more information, or to make an appointment, call 866-205-8262 or visit http://www.numale.com.

About NuMale Medical Center

NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation and low sex drive, utilizing a wide range of the most highly-respected, FDA-approved treatments. NuMale’s innovative services include bio-identical hormone replacement, NeoGraft

News About How to Avoid Painful Bladder Stones and What to Do if You Get Them


(PRWEB) June 19, 2014

Bladder stones are exactly what they sound like; hard stone-like pieces of concentrated urine which have crystallized and clumped together. Interestingly enough, in developing nations, bladder stones are fairly common in children and sadly, as a result of dehydration, infection and a low-protein diet. In the U.S., bladder stones tend to occur primarily in adults, and men over the age of 30 are the most vulnerable.

How stones get in the bladder

While water makes up the majority of urine content, about five percent is made up of minerals and salts along with proteins and other waste products. When urine becomes overly concentrated due to dehydration, infection or other problems the color will vary from dark amber to brown depending on the types of waste and minerals it contains.

Bladder stones can become so large or numerous that they block the tube (called a urethra) that urine flows through from the bladder. A blocked urethra may cause slow and/or painful urination or it might make urination impossible. Sometimes, bladder stones cause no problems at all even when stones become quite large. However, real problems begin to develop as stones irritate the bladder wall or block the flow of urine, causing a variety of symptoms including:

- Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction


– Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction

from Medizin – Open Access LMU – Teil 08/08

Price:
View Details about

Testosterone Lawsuit Accuses Drugs Manufacturers of Engaging in Deceptive Marketing, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) November 14, 2014

A testosterone lawsuit (http://www.testosteronelawsuithub.com/) recently filed in the multidistrict litigation now underway in the U.S. District Court, Northern District of Illinois, is seeking reimbursement for the costs insurance companies incurred covering prescriptions for AndroGel, Testopel, Axiron, Androderm and Fortesta Gel, Bernstein Liebhard LLP reports. The November 5th filing alleges that the manufacturers of testosterone therapies engaged in deceptive marketing, and caused insurers to pay billions of dollars for unsafe and ineffective medications. Among other things, the class action lawsuit points out that federal regulators have only approved testosterone replacement drugs for the treatment of hypogonadism (low testosterone) caused by an underlying medical condition. However, the complaint asserts that pharmaceutical companies marketed testosterone products as treatments for age-related issues, such as erectile dysfunction, diabetes, depression, and obesity. (Case No. 1:2014cv08857)

This complaint joins more than 200 other testosterone lawsuits that have been filed in Illinois on behalf of men who allegedly suffered serious heart problems due to their use of AndroGel and similar treatments. These lawsuits also put forth similar allegations regarding the marketing tactics used to drive sales of the drugs, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free case reviews to victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems that were allegedly caused by prescription testosterone medication.

Testosterone Litigation

According to court documents, more than 220 testosterone lawsuits are now pending in the litigation underway in the Northern District of Illinois, all of which claim that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential cardiovascular risks, and concealed those dangers from the public. The lawsuits further allege that the manufacturers of the medications engaged in deceptive advertising that induced many men to use the potentially dangerous treatments, even though they had no real medical need for testosterone replacement therapy. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Court documents indicate that the litigation involving testosterone treatments has been growing since January, when the U.S. Food & Drug Administration (FDA) launched a safety review of their cardiovascular risks. In September, a panel of outside advisors convened by the FDA recommended that the manufacturers of the medications be required to conduct studies of their cardiovascular side effects. The advisors also recommended that the labeling for low testosterone therapies be revised to make clear they have not been shown to lessen symptoms typically associated with aging in men.*

Men who allegedly suffered heart attacks, strokes, blood clots and other serious cardiovascular events due to low testosterone therapy may be entitled to file their own testosterone lawsuit. To learn more, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

BPH Treatments with Surgery Must Be Used When Urinary Obstruction is Substantial as Dr. Allens Device Treats this Problem Naturally, Reports Fine Treatment


London, GB (PRWEB) November 20, 2014

According to a recent article in the Renal and Urology News, transurethral resection of the prostate (TURP) is still the most common surgical treatment for benign prostatic hyperplasia (BPH), but its rate of use has been declining in the wake of a growing popularity of laser prostatectomies. However after both surgeries men can suffer from different side effects. At the same time prostate enlargement can be terminated and reversed with the use of Dr. Allens Device, so this harmless therapy ought to be tried in the first place when a man is diagnosed with BPH.

The article Laser Surgery Gaining on Transurethral Resection (TURP) for Enlarged Prostate, dated November 05, 2014, in the Renal and Urology News, says that patients aged 45 years or oldater were progressively less likely to receive laser treatments and furthermore patients with comorbidities were less likely to receive laser treatment.

The use of laser prostatectomy (coagulation, enucleation, or vaporization) rose significant from 6.4% of cases in 2000-2002 to 44.5% in 2009-2011, whereas the use of TURP declined significantly from 72.2% to 48.3% of cases during the same time periods, Dr. Chughtai’s team reported in the Journal of Endourology, on October 29, 2014. However, laser treatment was utilized more in younger patients, in those privately insured, in hospitals with high volumes of BPH procedures, and in patients with fewer comorbid conditions

However, both BPH surgical treatments have similar side effects which must be considered seriously, especially when these options are discussed with younger patients. For instance, the article What Are the Possible Side Effects of Laser Prostate Surgery? explores that according to MayoClinic.com, laser prostate surgery can cause a range of urinary side effects, including urinary retention – problems urinating – and urinary tract infections. Laser surgery for an enlarged prostate gland can adversely affect the normal flow of sperm out of the penis, resulting in a condition called retrograde ejaculation. Rarely, certain laser prostate surgeries can cause erectile dysfunction, or impotence.

In most BPH cases, surgeries can now be replaced with the Thermobalancing therapy, as Dr. Allens therapeutic device is able to terminate prostate enlargement effectively. A video recorded by the Oxford Innovation Centre demonstrates how to use Dr Allens Device and what its benefits are: http://www.youtube.com/watch?v=V5xidswhxJM.

When the urinary obstruction is not extensive, Thermobalancing therapy is the crucial treatment option for enlarged prostate, notes Dr. Simon Allen. Dr. Allens Device reduces the troubling urinary symptoms gradually by reversing BPH naturally.

For more details, visit Fine Treatment at http://finetreatment.com/bph-treatment-prostate-enlargement.

About Dr. Simon Allen and Fine Treatment:

Dr. Simon Allen, MD, PhD, Academician, member of the ATA, is a highly experienced medical professional. His specialty is in internal medicine. He has treated a wide range of chronic diseases, including patients after a heart attack, stroke, with kidneys problems, including kidney stones disease, prostate and spine conditions, as well as metabolic disorders.

Fine Treatment ensures international availability of Dr. Allens Devices for the treatment of chronic prostatitis and BPH, coronary heart disease, for dissolving kidney stones, for a powerful relief of upper and lower back pain and sciatica, as well as for natural brain function support.







Related Erectile Dysfunction Press Releases

Kidney Stones Recurrence is up to 50% within 5 Years thus Natural Dr. Allens Device is the Best Treatment Option, Highlights Fine Treatment


London, GB (PRWEB) November 22, 2014

The American College of Physicians (ACP) has issued new, evidence-based guidelines on the comparative efficacy and safety of dietary and pharmacologic strategies to prevent recurrent kidney stones in adults, states a recent article in the Medscape. Treatment of recurrent kidney stones with extracorporeal shock wave lithotripsy (ESWL) and surgeries increases the risk of high blood pressure, diabetes and chronic kidney failure later in the life. That is why Dr. Allens Device that dissolves any type and size of kidney stones in both kidneys naturally should be used in the first place, Fine Treatment reveals.

The article Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults, published in the Annals of Internal Medicine on November 4, 2014, says that to prevent the recurrence of nephrolithiasis should be achieved by both dietary changes and appropriate pharmacologic approaches. Dietary changes include increasing water intake, reducing dietary oxalate, reducing dietary animal protein and other purines, and maintaining normal dietary calcium. And pharmacologic monotherapy includes a thiazide diuretic, citrate, or allopurinol.

According to the article Recurrent Kidney Stones: ACP Issues New Guidelines, dated November 4, 2014, in the Medscape, ACP President David Fleming, MD, said in a news release the following: Increased fluid intake spread throughout the day can decrease stone recurrence by at least half with virtually no side effects. However, people who already drink the recommended amount of liquids, or when increased fluid intake is contraindicated, should not increase their fluid intake.

Regarding pharmacologic monotherapy with a thiazide diuretic, citrate, or allopurinol, the article says that it is a weak recommendation based on moderate-quality evidence. Moreover, all these drugs were associated with adverse events. For thiazides, these were orthostasis, gastrointestinal upset, erectile dysfunction, fatigue, and muscle symptoms. Citrates were associated with gastrointestinal symptoms and allopurinol with rash, acute gout, and leukopenia.

Increased fluid intake to achieve at least 2 L of urine per day targets to improve the blood flow via kidneys but it can be achieved simply by using Dr. Allens Device for Kidney Care, comments Dr. Allen.

Contrary to current treatment options, Thermobalancing therapy enabled by Dr. Allens Device eases the symptoms of kidney stones first, gradually dissolving kidney stones over time. Watch the video here: http://www.youtube.com/watch?v=5Wo0BQ24D6U.

People should avoid complications, such as high blood pressure or diabetes after ESWL, says Dr. Simon Allen. Dr. Allens therapeutic device dissolves kidney stones and prevents their formation in the future.

Read more at: http://finetreatment.com/kidney-stones-treatment-kidney-stone/.

About Dr. Simon Allen and Fine Treatment:

Dr. Simon Allen, MD, PhD, Academician, member of the ATA, is a highly experienced medical professional. He specializes in internal medicine. He has treated a wide range of chronic diseases, including patients after a heart attack, with kidneys problems, including kidney stones disease, prostate and spine conditions, as well as metabolic disorders. Fine Treatment supports global customer outreach, and ensures international availability of Dr. Allens Devices for the treatment of chronic prostatitis and BPH, coronary heart disease, for dissolving kidney stones, as well as for easing headaches, dizziness, and relieving lower back pain and sciatica.







Related Erectile Dysfunction Treatment Press Releases